Improved long-term survival for unresectable hepatocellular carcinoma (HCC) with a combination of surgery and intrahepatic arterial infusion of 131 I-anti-HCC mAb. Phase I/II clinical trials
- 19 May 1998
- journal article
- clinical trial
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 124 (5), 275-280
- https://doi.org/10.1007/s004320050166